These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28718903)

  • 21. Developing pharmacogenetic evidence throughout clinical development.
    Burns DK
    Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gene editing in drug discovery and therapeutic innovation].
    Galzi JL
    Med Sci (Paris); 2019 Apr; 35(4):309-315. PubMed ID: 31038108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closing the drug lag for new drug submission and review in Japan: An industry perspective.
    Poirier AF
    Clin Pharmacol Ther; 2015 Nov; 98(5):486-8. PubMed ID: 26239646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Industry and regulatory performance in 2012: a year in review.
    Dowden HM; Jahn R; Catka T; Jonsson A; Michael E; Miwa Y; Zinkand W
    Clin Pharmacol Ther; 2013 Sep; 94(3):359-66. PubMed ID: 23657160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
    Jackson N; Atar D; Borentain M; Breithardt G; van Eickels M; Endres M; Fraass U; Friede T; Hannachi H; Janmohamed S; Kreuzer J; Landray M; Lautsch D; Le Floch C; Mol P; Naci H; Samani NJ; Svensson A; Thorstensen C; Tijssen J; Vandzhura V; Zalewski A; Kirchhof P
    Eur Heart J; 2016 Mar; 37(9):747-54. PubMed ID: 26077039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 29. Trends in risks associated with new drug development: success rates for investigational drugs.
    DiMasi JA; Feldman L; Seckler A; Wilson A
    Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need for precompetitive integrative bionetwork disease model building.
    Friend SH
    Clin Pharmacol Ther; 2010 May; 87(5):536-9. PubMed ID: 20407459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symposium zeroes in on new discoveries in breast cancer.
    Printz C
    Cancer; 2011 Mar; 117(6):1107-8. PubMed ID: 21381004
    [No Abstract]   [Full Text] [Related]  

  • 32. The productivity crisis in pharmaceutical R&D.
    Pammolli F; Magazzini L; Riccaboni M
    Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partnering for therapeutics discovery.
    Colvis CM; Devaney S; Brady LS; Hudson KL
    Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
    [No Abstract]   [Full Text] [Related]  

  • 34. Vas Narasimhan.
    Narasimhan V; Mullard A
    Nat Rev Drug Discov; 2016 Jan; 15(1):10-1. PubMed ID: 26718275
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 36. An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987-2011.
    Lanthier M; Miller KL; Nardinelli C; Woodcock J
    Health Aff (Millwood); 2013 Aug; 32(8):1433-9. PubMed ID: 23918488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An industrial perspective on contemporary applications of PBPK models in drug discovery and development.
    Smith BJ
    Biopharm Drug Dispos; 2012 Mar; 33(2):53-4. PubMed ID: 22407480
    [No Abstract]   [Full Text] [Related]  

  • 38. Virtual drug discovery with the rise of Chinese CROs.
    Zhang MQ
    Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343
    [No Abstract]   [Full Text] [Related]  

  • 39. [Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].
    Akaike A
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):254-9. PubMed ID: 24813797
    [No Abstract]   [Full Text] [Related]  

  • 40. An audience with...John Reed.
    Reed J; Mullard A
    Nat Rev Drug Discov; 2014 Mar; 13(3):170-1. PubMed ID: 24577393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.